Rothschild & Co Asset Management US’s Globus Medical GMED Stock Holding History

Rothschild & Co Asset Management US’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-157,464	Closed	-$4.38M	–	533
2015 Q4	$4.38M	Buy	157,464 +24,673	+19%	+$619K	0.08%	277
2015 Q3	$2.74M	Sell	132,791 -132,489	-50%	-$3.36M	0.05%	293
2015 Q2	$6.81M	Sell	265,280 -76,703	-22%	-$1.94M	0.13%	234
2015 Q1	$8.63M	Buy	341,983 +3,415	+1%	+$83.2K	0.16%	209
2014 Q4	$8.05M	Sell	338,568 -11,219	-3%	-$248K	0.16%	193
2014 Q3	$6.88M	Buy	+349,787	New	+$7.2M	0.15%	216

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Rothschild & Co Asset Management US's GMED Position: Q1 2016 in Review

Rothschild & Co Asset Management US sold out of Globus Medical (GMED) in Q1 2016, closing a stake of 157,464 shares — an estimated $4.38M sold.

Rothschild & Co Asset Management US first reported a position in GMED in Q3 2014 and held it in 6 quarters. The position peaked at $8.63M in Q1 2015. 204 funds tracked by Wall St. Rank hold GMED as of Q1 2016.

Rothschild & Co Asset Management US reported no remaining Globus Medical position as of Q1 2016 after selling out during the quarter.
Rothschild & Co Asset Management US sold 157,464 Globus Medical shares in Q1 2016, an estimated $4.38M.
Rothschild & Co Asset Management US first reported a position in Globus Medical in Q3 2014 and held it in 6 quarters.
Rothschild & Co Asset Management US's Globus Medical position peaked at $8.63M in Q1 2015.
204 funds tracked by Wall St. Rank held Globus Medical as of Q1 2016.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2016, filed 13 May 2016.